These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27293576)

  • 1. Hyperparathyroid bone disease.
    Nigam A; Kan G; Morris E
    Clin Kidney J; 2013 Aug; 6(4):441-2. PubMed ID: 27293576
    [No Abstract]   [Full Text] [Related]  

  • 2. Can hyperparathyroid bone disease be arrested or reversed?
    Olgaard K; Lewin E
    Clin J Am Soc Nephrol; 2006 May; 1(3):367-73. PubMed ID: 17699233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy.
    Phitayakorn R; McHenry CR
    J Am Coll Surg; 2008 Jun; 206(6):1106-15. PubMed ID: 18501807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Electron microscopic evaluation of bone from a patient treated with cinacalcet hydrochloride, maxacalcitol, and alfacalcidol for hyperparathyroid bone disease with secondary hyperparathyroidism.
    Yajima A; Tsuchiya K; Bonewald LF; Inaba M; Tominaga Y; Tanizawa T; Ito A; Nitta K
    Osteoporos Int; 2018 May; 29(5):1203-1209. PubMed ID: 29492624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new assay method that detects only intact osteocalcin. Two-step non-invasive diagnosis to predict adynamic bone disease in haemodialysed patients.
    Morishita T; Nomura M; Hanaoka M; Saruta T; Matsuo T; Tsukamoto Y
    Nephrol Dial Transplant; 2000 May; 15(5):659-67. PubMed ID: 10809807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation.
    Blair HC; Dong SS; Julian BA
    Virchows Arch; 1999 Jul; 435(1):50-7. PubMed ID: 10431846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium oxalate crystal formation in patients with hyperparathyroidism and hyperthyroidism and related metabolic disturbances.
    Kohri K; Kodama M; Umekawa T; Ishikawa Y; Katayama Y; Takada M; Katoh Y; Kataoka K; Iguchi M; Kurita T
    Bone Miner; 1990 Jan; 8(1):59-67. PubMed ID: 2306555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperparathyroid bone disease in chronic renal failure.
    Cundy T; Hamdy N; Gray R; Jackson B; Kanis JA
    Ulster Med J; 1985 Aug; 54 Suppl(Suppl):S34-43. PubMed ID: 3909581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of renal osteodystrophy in dialysis patients: use of bone alkaline phosphatase, bone mineral density and parathyroid ultrasound in comparison with bone histology.
    Fletcher S; Jones RG; Rayner HC; Harnden P; Hordon LD; Aaron JE; Oldroyd B; Brownjohn AM; Turney JH; Smith MA
    Nephron; 1997; 75(4):412-9. PubMed ID: 9127327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperparathyroid crisis reviewed: a role for parenteral cimetidine?
    Sherwood JK; Garcia M; Ackroyd FW; Glick H; Minervini D; Goldstone RJ
    Am Surg; 1986 Jun; 52(6):320-32. PubMed ID: 3521423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of hyperparathyroid bone disease and the review of renal osteodystrophy].
    Soejima M; Takasugi M; Kuroiwa A; Okajima T; Zeze F
    Fukuoka Igaku Zasshi; 1992 Jul; 83(7):319-21. PubMed ID: 1398425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperparathyroidism and anemia: experimental study in the rat (author's transl)].
    Lacour B; Basile C; Drüeke T
    Nephrologie; 1980; 1(1):9-14. PubMed ID: 7301019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients.
    Lips P; Netelenbos JC; van Doorn L; Hackeng WH; Lips CJ
    Clin Endocrinol (Oxf); 1991 Jul; 35(1):35-40. PubMed ID: 1909609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone loss in primary hyperparathyroidism.
    Gryfe CI
    Can Med Assoc J; 1973 Sep; 109(6):479-82. PubMed ID: 4742915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperparathyroid bone disease in diabetic renal failure.
    Cundy TF; Humphreys S; Watkins PJ; Parsons V
    Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous calcitonin does not protect against hyperparathyroid bone disease in renal failure.
    Malluche HH; Faugère MC; Ritz E; Caillens G; Wildberger D
    Miner Electrolyte Metab; 1986; 12(2):113-8. PubMed ID: 3960014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modeling hyperparathyroid osteodystrophy in animals].
    Spuzjak MI
    Radiol Diagn (Berl); 1989; 30(6):697-702. PubMed ID: 2608905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperparathyroid crisis in a patient with a giant brown tumor of the iliac bone: a case report.
    Ishikawa S; Ozaki T; Kawai A; Inoue H; Doihara H
    Hiroshima J Med Sci; 1998 Mar; 47(1):27-30. PubMed ID: 9583280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.